The sold production of diagnostic reagents and other pharmaceutical preparations in Denmark, expressed in million Euros, showed significant variability over time. From 2013 to 2016, there was a downward trend, experiencing drops with a major decline in 2016. The industry saw a recovery starting in 2017, with notable growth spikes in 2018 and particularly in 2021, where a 40.12% year-on-year increase was observed. The years 2022 and 2023 showed modest growth with rates of 0.79% and 0.91% respectively. As of 2023, the value stood at 24.9 million Euros.
For the next five years, the compound annual growth rate (CAGR) is anticipated to be 0.68%, translating to an overall growth rate of 3.45% through to 2028. This indicates a period of stabilization following significant fluctuation in the past decade.
Future trends to watch for include innovations in pharmaceutical technology, regulatory changes, and market responses to global health trends. Continued investments in R&D and healthcare advancements could drive further growth, while economic factors might pose risks.
